2-Aminoacetophenone as a potential breath biomarker for <it>Pseudomonas aeruginosa </it>in the cystic fibrosis lung

2-Aminoacetophenone as a potential breath biomarker for <it>Pseudomonas aeruginosa </it>in the cystic fibrosis lung

<p>Abstract</p> <p>Background</p> <p><it>Pseudomonas aeruginosa </it>infections are associated with progressive life threatening decline of lung function in cystic fibrosis sufferers. Growth of <it>Ps. aeruginosa </it>releases a "grape-like&...

Full description

Bibliographic Details
Main Authors:	Laing Richard, Epton Michael, Pattemore Philip K, Syhre Mona, Scott-Thomas Amy J, Pearson John, Chambers Stephen T
Format:	Article
Language:	English
Published:	BMC 2010-11-01
Series:	BMC Pulmonary Medicine
Online Access:	http://www.biomedcentral.com/1471-2466/10/56

Similar Items

2-Aminoacetophenone As A Virulent Factor For Pseudomonas Aeruginosa Causing Sever Burn And Wound Infections In Iraq
by: M.K. Al-Araji, et al.
Published: (2017-05-01)

Exhaled breath hydrogen cyanide as a marker of early Pseudomonas aeruginosa infection in children with cystic fibrosis
by: Francis J. Gilchrist, et al.

Interactions between Neutrophils and Pseudomonas aeruginosa in Cystic Fibrosis
by: Balázs Rada
Published: (2017-03-01)

Coinfection with Pseudomonas aeruginosa and Aspergillus fumigatus in cystic fibrosis
by: Karen Keown, et al.
Published: (2020-11-01)

Management of refractory Pseudomonas aeruginosa infection in cystic fibrosis
by: Roger Sord&eacute;, et al.
Published: (2011-01-01)

Alkyl-Quinolones derivatives as potential biomarkers for Pseudomonas aeruginosa infection chronicity in Cystic Fibrosis
by: Serge Michalet, et al.
Published: (2021-10-01)

CD14 C-159T and early infection with <it>Pseudomonas aeruginosa </it>in children with cystic fibrosis
by: Sly PD, et al.
Published: (2005-06-01)

Interaction between Pseudomonas aeruginosa and Aspergillus fumigatus in cystic fibrosis
by: Jingming Zhao, et al.
Published: (2018-11-01)

Adherence of Pseudomonas aeruginosa to cystic fibrosis buccal epithelial cells
by: Meike Lingner, et al.
Published: (2017-01-01)

The Effect of Strict Segregation on Pseudomonas aeruginosa in Cystic Fibrosis Patients.
by: Rosa van Mansfeld, et al.
Published: (2016-01-01)

Recent advances in the treatment of <it>Pseudomonas aeruginosa </it>infections in cystic fibrosis
by: Høiby Niels
Published: (2011-04-01)

Antibiotic perturbation of mixed-strain Pseudomonas aeruginosa infection in patients with cystic fibrosis
by: Anna S. Tai, et al.
Published: (2017-11-01)

Genetic relatedness and host specificity of Pseudomonas aeruginosa isolates from cystic fibrosis and non-cystic fibrosis patients
by: AbdulWahab A, et al.
Published: (2014-11-01)

Estrogen aggravates inflammation in <it>Pseudomonas aeruginosa </it>pneumonia in cystic fibrosis mice
by: Gagnon Stéphane, et al.
Published: (2010-11-01)

Phenotypic heterogeneity of Pseudomonas aeruginosa populations in a cystic fibrosis patient.
by: Matthew L Workentine, et al.
Published: (2013-01-01)

Clinical outcomes of cystic fibrosis patients with Pseudomonas aeruginosa bloodstream infection
by: Andrei Zidaru, et al.
Published: (2022-06-01)

Bilateral Pseudomonas aeruginosa keratitis as presenting feature in an infant of cystic fibrosis
by: Meena Lakshmipathy, et al.
Published: (2022-01-01)

The susceptibility of Pseudomonas aeruginosa strains from cystic fibrosis patients to bacteriophages.
by: Christiane Essoh, et al.
Published: (2013-01-01)

Antibiotic Susceptibility of Pseudomonas Aeruginosa Isolated from Cystic Fibrosis Patients
by: Soltan Dallal, MM, et al.
Published: (2015-01-01)

Quorum-Sensing Signaling Molecule 2-Aminoacetophenone Mediates the Persistence of Pseudomonas aeruginosa in Macrophages by Interference with Autophagy through Epigenetic Regulation of Lipid Biosynthesis
by: Arijit Chakraborty, et al.
Published: (2023-04-01)

Catabolism of Nucleic Acids by a Cystic Fibrosis Pseudomonas aeruginosa Isolate: An Adaptive Pathway to Cystic Fibrosis Sputum Environment
by: Sheemal Shanista Kumar, et al.
Published: (2019-05-01)

Pooling isolates to address the diversity in antimicrobial susceptibility of Pseudomonas aeruginosa in cystic fibrosis
by: Sara Van den Bossche, et al.
Published: (2023-12-01)

Bile effects on the Pseudomonas aeruginosa pathogenesis in cystic fibrosis patients with gastroesophageal reflux
by: Mobina Bayat, et al.
Published: (2023-11-01)

22: GENOMIC EPIDEMIOLOGY OF PSEUDOMONAS AERUGINOSA IN CYSTIC FIBROSIS PATIENTS IN WESTERN AUSTRALIA
by: Daniel Knight, Dr, et al.
Published: (2022-11-01)

Polymorphonuclear leukocytes restrict growth of pseudomonas aeruginosa in the lungs of cystic fibrosis patients
by: Moser, Claus, et al.
Published: (2015)

Human cysteine cathepsins are not reliable markers of infection by Pseudomonas aeruginosa in cystic fibrosis.
by: Clément Naudin, et al.
Published: (2011-01-01)

Pyoverdine-Dependent Virulence of Pseudomonas aeruginosa Isolates From Cystic Fibrosis Patients
by: Donghoon Kang, et al.
Published: (2019-09-01)

In vitro Interactions of Pseudomonas aeruginosa With Scedosporium Species Frequently Associated With Cystic Fibrosis
by: Mónika Homa, et al.
Published: (2019-03-01)

The emergence of multidrug-resistant Pseudomonas aeruginosa in cystic fibrosis patients on inhaled antibiotics
by: Atqah AbdulWahab, et al.
Published: (2017-01-01)

Acute intratracheal <it>Pseudomonas aeruginosa </it>infection in cystic fibrosis mice is age-independent
by: Munder Antje, et al.
Published: (2011-11-01)

Genotypic characterization of Pseudomonas aeruginosa isolates from Turkish children with cystic fibrosis
by: Sener Okur D, et al.
Published: (2019-03-01)

The role of Psl in the failure to eradicate Pseudomonas aeruginosa biofilms in children with cystic fibrosis
by: Amanda J. Morris, et al.
Published: (2021-08-01)

The efficacy of biosynthesized silver nanoparticles against Pseudomonas aeruginosa isolates from cystic fibrosis patients
by: Hafez Al-Momani, et al.
Published: (2023-06-01)

Pseudomonas aeruginosa transcriptome analysis of metal restriction in ex vivo cystic fibrosis sputum
by: Samuel L. Neff, et al.
Published: (2024-04-01)

In vitro activity of cefiderocol against Pseudomonas aeruginosa isolated from cystic fibrosis patients
by: Marguerite L. Monogue, et al.
Published: (2023-12-01)

Pseudomonas aeruginosa Diversification during Infection Development in Cystic Fibrosis Lungs—A Review
by: Ana Margarida Sousa, et al.
Published: (2014-08-01)

To bead or not to bead: A review of Pseudomonas aeruginosa lung infection models for cystic fibrosis
by: Nicole Reyne, et al.
Published: (2023-02-01)

2301 Mucoidal pseudomonas aeruginosa infection is associated with regional inflammation in the cystic fibrosis lung
by: Sankalp Malhotra, et al.
Published: (2018-06-01)

Systemic oxidative stress in children with cystic fibrosis with bacterial infection including Pseudomonas Aeruginosa
by: Gabriela Datsch Bennemann, et al.
Published: (2022-06-01)

Impact of concomitant nontuberculous mycobacteria and Pseudomonas aeruginosa isolates in non-cystic fibrosis bronchiectasis
by: Hsieh MH, et al.
Published: (2018-08-01)